In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study
- PMID: 27287766
- PMCID: PMC4929091
- DOI: 10.1007/s40121-016-0112-3
In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study
Erratum in
-
Erratum to: In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study.Infect Dis Ther. 2016 Sep;5(3):405. doi: 10.1007/s40121-016-0120-3. Infect Dis Ther. 2016. PMID: 27424199 Free PMC article. No abstract available.
Abstract
Introduction: Bacterial infections that cause community-acquired urinary tract infections (CA-UTI) and upper respiratory tract infections (CA-URTI) are most frequently treated empirically. However, an increase in antimicrobial resistance has become a problem when treating outpatients.
Methods: This study determined the in vitro activities of oral antibiotics among 1501 pathogens from outpatients with CA-UTI and CA-URTI in medical centers during 2012 and 2013 from Argentina, Mexico, Venezuela, Russia, and the Philippines. Minimal inhibitory concentrations (MICs) were determined using broth microdilution and susceptibility defined by Clinical Laboratory Standards Institute (CLSI) and European Committee for Antimicrobial Susceptibility Testing (EUCAST) criteria.
Results: Ceftibuten (MIC50, ≤0.25 mg/L) was more potent in vitro compared to other β-lactams against Enterobacteriaceae from CA-UTI. Susceptibility to fluoroquinolones using CLSI criteria varied: Argentina and Mexico (50%), the Philippines (60%), Venezuela (70%), and Russia (80%). Fosfomycin susceptibility was >90% against Enterobacteriaceae in each country. Susceptibility among Enterobacteriaceae to trimethoprim-sulfamethoxazole was 30.6-75.6% and nitrofurantoin susceptibility also varied among the countries and was higher when EUCAST breakpoints were applied (65->90%) compared to CLSI (52-84%). All Haemophilus influenzae isolates from CA-URTI were susceptible to ceftibuten, cefixime, cefpodoxime, and cefuroxime using CLSI breakpoint criteria. EUCAST criteria produced intermediate and resistant MIC values for these oral cephalosporins. Country-specific susceptibility variation for fluoroquinolones, macrolides, and trimethoprim-sulfamethoxazole was observed among Streptococcus pneumoniae and Streptococcus pyogenes from CA-URTI.
Conclusion: This study demonstrated that antimicrobial susceptibility patterns varied in the five countries investigated among pathogens from CA-UTI and CA-URTI.
Funding: Merck & Co. Inc., Kenilworth, New Jersey, USA.
Keywords: Community-acquired UTI and RTI; Oral antibiotics; Prescribing practices; Resistance.
Similar articles
-
Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i76-i87. doi: 10.1093/jac/dkaa085. J Antimicrob Chemother. 2020. PMID: 32337594
-
Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i43-i59. doi: 10.1093/jac/dkaa083. J Antimicrob Chemother. 2020. PMID: 32337593
-
Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.J Antimicrob Chemother. 2018 Apr 1;73(suppl_5):v14-v21. doi: 10.1093/jac/dky065. J Antimicrob Chemother. 2018. PMID: 29659881
-
In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.Clin Infect Dis. 2000 Aug;31 Suppl 2:S16-23. doi: 10.1086/314054. Clin Infect Dis. 2000. PMID: 10984323 Review.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli.Front Cell Infect Microbiol. 2016 Oct 31;6:135. doi: 10.3389/fcimb.2016.00135. eCollection 2016. Front Cell Infect Microbiol. 2016. PMID: 27843814 Free PMC article.
References
-
- Bantar C, Curcio D, Jasovich A, et al. Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II) Rev Chilena Infectol. 2010;27(Suppl 1):S9–S38. - PubMed
-
- Bours PH, Polak R, Hoepelman AI, Delgado E, Jarquin A, Matute AJ. Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines. Int J Infect Dis. 2010;14:770–774. doi: 10.1016/j.ijid.2010.02.2264. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases